Data Portal @ linkeddatafragments.org

Matches in DBpedia 2014 for { ?s ?p Adolf Merckle (18 March 1934 – 5 January 2009) was an entrepreneur and one of the richest people in Germany.Merckle was born in Dresden, Germany into a wealthy family. He developed his Bohemian grandfather's chemical wholesale company into Germany's largest pharmaceutical wholesaler, Phoenix Pharmahandel. In the early 1970s he founded Germany's first generic drug manufacturer Ratiopharm. Over decades he also held large parts of cement company HeidelbergCement as well as vehicle manufacturer Kässbohrer.He was educated as a lawyer but spent most of his time investing in and developing his companies. He lived in Germany with his wife and four children.In 2007, he was worth US$12.8 billion by most estimates (Forbes), and by December 2008 he was worth $9.2 billion, a loss of $3.6 billion. In 2006, he was the world's 44th richest man, dropping to 96th place by December 2008, but still one of Germany's five richest men.End of 2008 Merckle’s investment company VEM faced a liquidity shortage. VEM said in a public statement that it had shored up the equity capital of HeidelbergCement to support the acquisition of British cement maker Hanson using loans backed by shares as collateral. Since the market value of the shares slumped more than 75% in the financial crisis, banks demanded further securities and early redemption on their loans. Merckle made personal guarantees to the banks, also from his private assets. By negotiating with the banks he received a bridge loan to keep VEM afloat. In return he had to agree to sell ratiopharm and stakes of HeidelbergCement to pay down debt.Also in 2008 Merckle had made a speculative investment based on his belief that Volkswagen shares would fall; however, in October 2008, Porsche SE's support of Volkswagen sent shares on the Xetra dax from €210.85 to over €1000 in less than two days (a short squeeze), resulting in losses of a low three-digit million in euros. When the liquidity shortage of VEM became public, media came up with speculations that this was caused by the losses from options on Volkswagen stock. Later it turned out that this was not the case. Neither the amount nore the companies involved were related to the banking negotiations and the following restructuring.. }

• Adolf_Merckle abstract "Adolf Merckle (18 March 1934 – 5 January 2009) was an entrepreneur and one of the richest people in Germany.Merckle was born in Dresden, Germany into a wealthy family. He developed his Bohemian grandfather's chemical wholesale company into Germany's largest pharmaceutical wholesaler, Phoenix Pharmahandel. In the early 1970s he founded Germany's first generic drug manufacturer Ratiopharm. Over decades he also held large parts of cement company HeidelbergCement as well as vehicle manufacturer Kässbohrer.He was educated as a lawyer but spent most of his time investing in and developing his companies. He lived in Germany with his wife and four children.In 2007, he was worth US$12.8 billion by most estimates (Forbes), and by December 2008 he was worth $9.2 billion, a loss of $3.6 billion. In 2006, he was the world's 44th richest man, dropping to 96th place by December 2008, but still one of Germany's five richest men.End of 2008 Merckle’s investment company VEM faced a liquidity shortage. VEM said in a public statement that it had shored up the equity capital of HeidelbergCement to support the acquisition of British cement maker Hanson using loans backed by shares as collateral. Since the market value of the shares slumped more than 75% in the financial crisis, banks demanded further securities and early redemption on their loans. Merckle made personal guarantees to the banks, also from his private assets. By negotiating with the banks he received a bridge loan to keep VEM afloat. In return he had to agree to sell ratiopharm and stakes of HeidelbergCement to pay down debt.Also in 2008 Merckle had made a speculative investment based on his belief that Volkswagen shares would fall; however, in October 2008, Porsche SE's support of Volkswagen sent shares on the Xetra dax from €210.85 to over €1000 in less than two days (a short squeeze), resulting in losses of a low three-digit million in euros. When the liquidity shortage of VEM became public, media came up with speculations that this was caused by the losses from options on Volkswagen stock. Later it turned out that this was not the case. Neither the amount nore the companies involved were related to the banking negotiations and the following restructuring.".